189 related articles for article (PubMed ID: 38201285)
61. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
[TBL] [Abstract][Full Text] [Related]
62. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F
Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384
[TBL] [Abstract][Full Text] [Related]
63. Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.
Naito T; Umemura S; Nakamura H; Zenke Y; Udagawa H; Kirita K; Matsumoto S; Yoh K; Niho S; Motoi N; Aokage K; Tsuboi M; Ishii G; Goto K
Thorac Cancer; 2019 May; 10(5):1285-1288. PubMed ID: 30972962
[TBL] [Abstract][Full Text] [Related]
64. SMARCA4 biology in alveolar rhabdomyosarcoma.
Bharathy N; Cleary MM; Kim JA; Nagamori K; Crawford KA; Wang E; Saha D; Settelmeyer TP; Purohit R; Skopelitis D; Chang K; Doran JA; Kirschbaum CW; Bharathy S; Crews DW; Randolph ME; Karnezis AN; Hudson-Price L; Dhawan J; Michalek JE; Ciulli A; Vakoc CR; Keller C
Oncogene; 2022 Mar; 41(11):1647-1656. PubMed ID: 35094009
[TBL] [Abstract][Full Text] [Related]
65. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
Matsushita M; Kuwamoto S
Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
[TBL] [Abstract][Full Text] [Related]
66. Congenital Teratocarcinosarcoma With
Almarzooqi S; Reyes-Múgica M; Ali BR; Habbal A; Asha MJ; AlShamsi ET
Pediatr Dev Pathol; 2022; 25(5):562-567. PubMed ID: 35732187
[TBL] [Abstract][Full Text] [Related]
67. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract][Full Text] [Related]
68. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
[No Abstract] [Full Text] [Related]
69. Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status.
Salem F; Rosenblum MK; Jhanwar SC; Kancherla P; Ghossein RA; Carlson DL
Hum Pathol; 2008 Apr; 39(4):605-9. PubMed ID: 18284932
[TBL] [Abstract][Full Text] [Related]
70. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
Jelinic P; Schlappe BA; Conlon N; Tseng J; Olvera N; Dao F; Mueller JJ; Hussein Y; Soslow RA; Levine DA
Mod Pathol; 2016 Jan; 29(1):60-6. PubMed ID: 26564006
[TBL] [Abstract][Full Text] [Related]
71. Germline pathogenic
Witkowski L; Nichols KE; Jongmans M; van Engelen N; de Krijger RR; Herrera-Mullar J; Tytgat L; Bahrami A; Mar Fan H; Davidson AL; Robertson T; Anderson M; Hasselblatt M; Plon SE; Foulkes WD
J Med Genet; 2023 Oct; 60(10):987-992. PubMed ID: 36813544
[TBL] [Abstract][Full Text] [Related]
72. Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable β-catenin Overexpression and a β-catenin Mutation.
Birkeland AC; Burgin SJ; Yanik M; Scott MV; Bradford CR; McHugh JB; McLean SA; Sullivan SE; Nor JE; McKean EL; Brenner JC
J Neurol Surg B Skull Base; 2017 Aug; 78(4):346-352. PubMed ID: 28725522
[No Abstract] [Full Text] [Related]
73. Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Lissanu Deribe Y; Sun Y; Terranova C; Khan F; Martinez-Ledesma J; Gay J; Gao G; Mullinax RA; Khor T; Feng N; Lin YH; Wu CC; Reyes C; Peng Q; Robinson F; Inoue A; Kochat V; Liu CG; Asara JM; Moran C; Muller F; Wang J; Fang B; Papadimitrakopoulou V; Wistuba II; Rai K; Marszalek J; Futreal PA
Nat Med; 2018 Jul; 24(7):1047-1057. PubMed ID: 29892061
[TBL] [Abstract][Full Text] [Related]
74. [Sinonasal teratocarcinosarcoma].
Ila K; Işeri M; Erdoğan S; Keskin G; Koç K; Müezzinoğlu B
Kulak Burun Bogaz Ihtis Derg; 2014; 24(4):237-41. PubMed ID: 25046074
[TBL] [Abstract][Full Text] [Related]
75. SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas.
Panozzi M; Alì G; Proietti A; Melfi F; Zirafa CC; Lucchi M; Fontanini G
Pathologica; 2023 Jun; 115(3):164-171. PubMed ID: 37387441
[TBL] [Abstract][Full Text] [Related]
76. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract][Full Text] [Related]
77. Sinonasal teratocarcinosarcoma.
Sobani ZA; Akhtar S; Junaid M; Salahuddin I
J Pak Med Assoc; 2012 Jun; 62(6):633-5. PubMed ID: 22755362
[TBL] [Abstract][Full Text] [Related]
78. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract][Full Text] [Related]
79. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.
Kuwamoto S; Matsushita M; Takeda K; Tanaka N; Endo Y; Yamasaki A; Kohashi K; Oda Y; Horie Y
Hum Pathol; 2017 Dec; 70():92-97. PubMed ID: 28601660
[TBL] [Abstract][Full Text] [Related]
80. Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
Lin DI; Chudnovsky Y; Duggan B; Zajchowski D; Greenbowe J; Ross JS; Gay LM; Ali SM; Elvin JA
Gynecol Oncol; 2017 Dec; 147(3):626-633. PubMed ID: 29102090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
